Pergolide Treatment of Cognitive Deficits Associated with Schizotypal Personality Disorder: Continued Evidence of the Importance of the Dopamine System in the Schizophrenia Spectrum

[1]  Philip D. Harvey,et al.  The Effects of Guanfacine on Context Processing Abnormalities in Schizotypal Personality Disorder , 2007, Biological Psychiatry.

[2]  S. Marder.  Initiatives to promote the discovery of drugs to improve cognitive function in severe mental illness. , 2006, The Journal of clinical psychiatry.

[3]  P. Nathan,et al.  Molecular Imaging of the Dopaminergic System and its Association with Human Cognitive Function , 2006, Biological Psychiatry.

[4]  M. Kosmidis,et al.  Community dysfunction in schizophrenia: Rate-limiting factors , 2006, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[5]  M. D’Esposito,et al.  FUNCTIONAL MAGNETIC RESONANCE IMAGING STUDY OF THE FFECTS OF PERGOLIDE , A DOPAMINE RECEPTOR AGONIST , N COMPONENT PROCESSES OF WORKING MEMORY , 2006 .

[6]  Asaf Caspi,et al.  Premorbid Intellectual Functioning and Risk of Schizophrenia and Spectrum Disorders , 2006, Journal of clinical and experimental neuropsychology.

[7]  T. Robbins,et al.  Dopaminergic basis for deficits in working memory but not attentional set-shifting in Parkinson's disease , 2005, Neuropsychologia.

[8]  R. McCarley,et al.  Personality Differences in Schizophrenia Are Related to Performance on Neuropsychological Tasks , 2005, The Journal of nervous and mental disease.

[9]  S. Burton,et al.  Strategies for Improving Adherence to Second-Generation Antipsychotics in Patients with Schizophrenia by Increasing Ease of Use , 2005, Journal of psychiatric practice.

[10]  R. McCarley,et al.  Clinical, cognitive, and social characteristics of a sample of neuroleptic-naive persons with schizotypal personality disorder , 2005, Schizophrenia Research.

[11]  L. Siever,et al.  Neuropsychological performance in schizotypal personality disorder: importance of working memory. , 2005, The American journal of psychiatry.

[12]  Josef Parnas,et al.  Premorbid neurocognitive functioning in schizophrenia spectrum disorder. , 2005, Schizophrenia bulletin.

[13]  E. Stip,et al.  Cognitive predictors of psychosocial functioning outcome in schizophrenia: A follow-up study of subjects participating in a rehabilitation program , 2005, Schizophrenia Research.

[14]  Philip D. Harvey,et al.  Cognition in schizophrenia: impairments, determinants, and functional importance. , 2005, The Psychiatric clinics of North America.

[15]  C. Carter,et al.  Amphetamine improves cognitive function in medicated individuals with schizophrenia and in healthy volunteers , 2005, Schizophrenia Research.

[16]  E. Chen,et al.  A prospective 3-year longitudinal study of cognitive predictors of relapse in first-episode schizophrenic patients , 2005, Schizophrenia Research.

[17]  M. Hummer,et al.  Patient outcomes in schizophrenia II: the impact of cognition , 2005, European Psychiatry.

[18]  R. Heinrichs.  The primacy of cognition in schizophrenia. , 2005, The American psychologist.

[19]  N. Andreasen,et al.  Predictive values of neurocognition and negative symptoms on functional outcome in schizophrenia: a longitudinal first-episode study with 7-year follow-up. , 2005, The American journal of psychiatry.

[20]  René S. Kahn,et al.  Cognitive deficits in relatives of patients with schizophrenia: a meta-analysis , 2004, Schizophrenia Research.

[21]  Philip D. Harvey,et al.  Context-processing deficits in schizotypal personality disorder. , 2004, Journal of abnormal psychology.

[22]  P. Goldman-Rakic,et al.  Enhancement of Working Memory in Aged Monkeys by a Sensitizing Regimen of Dopamine D1 Receptor Stimulation , 2004, The Journal of Neuroscience.

[23]  Daniel Y. Kimberg,et al.  Cognitive effects of the dopamine receptor agonist pergolide , 2003, Neuropsychologia.

[24]  J. Trojanowski,et al.  Neuron‐specific age‐related decreases in dopamine receptor subtype mRNAs , 2003, The Journal of comparative neurology.

[25]  L. Siever,et al.  Neuropsychological performance in schizotypal personality disorder: evidence regarding diagnostic specificity , 2002, Biological Psychiatry.

[26]  Tim Shallice,et al.  Executive Function Profile of Children With Attention Deficit Hyperactivity Disorder , 2002, Developmental neuropsychology.

[27]  C. Harris,et al.  Adult attention-deficit/hyperactivity disorder: Neuropsychological correlates and clinical presentation , 2001, Brain and Cognition.

[28]  P. Goldman-Rakic,et al.  Reversal of antipsychotic-induced working memory deficits by short-term dopamine D1 receptor stimulation. , 2000, Science.

[29]  Philip D. Harvey,et al.  Visuospatial working memory in schizotypal personality disorder patients , 2000, Schizophrenia Research.

[30]  M. Naoi,et al.  Cell death of dopamine neurons in aging and Parkinson’s disease , 1999, Mechanisms of Ageing and Development.

[31]  P. Goldman-Rakic,et al.  The physiological approach: functional architecture of working memory and disordered cognition in schizophrenia , 1999, Biological Psychiatry.

[32]  N. Volkow,et al.  Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate. , 1998, The American journal of psychiatry.

[33]  S. Pollmann,et al.  D1- Versus D2-Receptor Modulation of Visuospatial Working Memory in Humans , 1998, The Journal of Neuroscience.

[34]  N. Volkow,et al.  Association between decline in brain dopamine activity with age and cognitive and motor impairment in healthy individuals. , 1998, The American journal of psychiatry.

[35]  R. Keefe,et al.  Performance of patients with schizophrenia on a pen and paper visuospatial working memory task with short delay , 1997, Schizophrenia Research.

[36]  Sharon K. McDowell,et al.  A Role for Dopamine in Executive Function Deficits , 1996 .

[37]  Edward E. Smith,et al.  A parametric study of prefrontal cortex involvement in human working memory , 1996, NeuroImage.

[38]  Larry J. Siever,et al.  Cognitive function and biological correlates of cognitive performance in schizotypal personality disorder , 1995, Psychiatry Research.

[39]  Douglas C. Noll,et al.  Activation of Prefrontal Cortex in Children during a Nonspatial Working Memory Task with Functional MRI , 1995, NeuroImage.

[40]  Philip D. Harvey,et al.  A pen-and-paper human analogue of a monkey prefrontal cortex activation task: spatial working memory in patients with schizophrenia , 1995, Schizophrenia Research.

[41]  P. Goldman-Rakic,et al.  Dopamine D1 receptor mechanisms in the cognitive performance of young adult and aged monkeys , 1994, Psychopharmacology.

[42]  Philip D. Harvey,et al.  Performance of nonpsychotic relatives of schizophrenic patients on cognitive tests , 1994, Psychiatry Research.

[43]  K. Davis,et al.  Dopamine in schizophrenia: a review and reconceptualization. , 1991, The American journal of psychiatry.

[44]  R. Gur,et al.  Neuropsychological function in schizophrenia. Selective impairment in memory and learning. , 1991, Archives of general psychiatry.

[45]  P. Goldman-Rakic,et al.  D1 dopamine receptors in prefrontal cortex: involvement in working memory , 1991, Science.

[46]  D. Stuss,et al.  Three tests of attention and rapid information processing: An extension , 1988 .

[47]  P. Goldman-Rakic,et al.  Regional changes of monoamines in cerebral cortex and subcortical structures of aging rhesus monkeys , 1981, Neuroscience.

[48]  H. E. Rosvold,et al.  Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey. , 1979, Science.

[49]  D. Gronwall.  Paced Auditory Serial-Addition Task: A Measure of Recovery from Concussion , 1977, Perceptual and motor skills.

[50]  Philip D. Harvey,et al.  Pharmacological Approaches to the Management of Cognitive Dysfunction in Schizophrenia , 2012, Drugs.

[51]  A. Verma.  Valvular Heart Disease and the Use of Dopamine Agonists for Parkinson's Disease , 2008 .

[52]  A. Verma,et al.  Dopamine Agonists and the Risk of Cardiac-Valve Regurgitation , 2008 .

[53]  Philip D. Harvey,et al.  Visual-spatial learning and memory in schizotypal personality disorder: continued evidence for the importance of working memory in the schizophrenia spectrum. , 2007, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

[54]  Michael F. Green,et al.  Cognitive impairment and functional outcome in schizophrenia and bipolar disorder. , 2006, The Journal of clinical psychiatry.

[55]  C. Tamminga.  The neurobiology of cognition in schizophrenia. , 2006, The Journal of clinical psychiatry.

[56]  C. Marsden,et al.  l-Dopa withdrawal in Parkinson's disease selectively impairs cognitive performance in tests sensitive to frontal lobe dysfunction , 2005, Psychopharmacology.

[57]  D. Barch,et al.  Working and long-term memory deficits in schizophrenia: is there a common prefrontal mechanism? , 2002, Journal of abnormal psychology.

[58]  R. Heinrichs,et al.  Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. , 1998, Neuropsychology.

[59]  F. J. White,et al.  Synaptic regulation of mesocorticolimbic dopamine neurons. , 1996, Annual review of neuroscience.

[60]  Robert A. Bornstein,et al.  The Wechsler Memory Scale—Revised , 1990 .

[61]  M. Schlossberg.  The Halstead-Reitan Neuropsychological Test Battery: Theory and Clinical Interpretation. , 1986 .